Cameroon has begun a historic mass rollout of the new malaria vaccine RTS,S, a development that the World Health Organization describes as life-saving. This initiative follows successful trials in Kenya, Ghana, and Malawi and is focused on children in regions most affected by malaria, aiming to significantly reduce the high number of cases and fatalities, particularly among children under five. The vaccine could potentially expand to other countries, including India, parts of southern Europe, and Latin America.
- The RTS,S malaria vaccine has launched in parts of Cameroon with the highest malaria rates.
- Cameroon reports approximately 6 million malaria cases and 4,000 deaths annually, mostly in children under five.
- The vaccine is the result of 30 years of research and is significant as it targets a complex parasite rather than a virus.
- More than 28 countries have expressed interest in the vaccine, signaling a high demand.
- Vaccine Alliance Gavi has secured funding for 18 million doses, though there is still a shortfall.
- Another vaccine, recommended by the WHO and produced by the Serum Institute of India, is awaiting regulatory approval and promises to fill gaps in supply.
- The cost of the vaccine rollout is supported by fundraising from the Vaccine Alliance and other organizations, minimizing financial impact on beneficiary countries.
- Priority for the vaccine rollout is given to countries with the greatest need.
The British Broadcasting Corporation is a British public service broadcaster headquartered at Broadcasting House in London. Originally established in 1922 as the British Broadcasting Company, it evolved into its current state with its current name on New Year’s Day 1927.
AllSides Media Bias Rating: Center
https://www.allsides.com/news-source/bbc-news-media-bias
Official website: https://www.bbc.com/
Original video here.
This summary has been generated by AI.
